In a recent final analysis of a phase 3 trial, the bivalent respiratory syncytial virus prefusion F (RSVpreF) vaccine maintained high efficacy and a favorable safety profile against RSV-associated ...

The World Health Organization (WHO) has announced that it has added Pfizer’s maternal respiratory syncytial virus (RSV) vaccine to its list of prequalified vaccines. Abrysvo, which is now the first ...

READ MORE: NHS Covid vaccine appointments now available to book Dr Alasdair Wood, consultant in health protection at UKHSA South West, said: "Our analysis clearly demonstrates the excellent benefit of ...

A new immunization program in Western Australia using the monoclonal antibody nirsevimab has significantly reduced hospital admissions for respiratory syncytial virus (RSV) in babies by nearly 90%.

The rollout of a vaccine for respiratory syncytial virus (RSV) has slashed hospital admissions by 30% among older people, according to early data. The benefits are likely to increase as more ...

U.S. IND clearance and revaccination trial initiation supports the differentiated global opportunity for Clover's RSV PreF vaccine (SCB-1019) utilizing validated Trimer-Tag platform ...

The Victorian government will offer free RSV vaccines for newborn babies from April to the end of September this year. The virus is the leading cause of hospital admissions for children aged up to ...

Moderna’s respiratory syncytial virus (RSV) vaccine mRESVIA has been approved by the Medicines and Healthcare products Regulatory Agency (MHRA) to protect adults aged 60 years and older against lower ...

"The MHRA's authorization of our RSV vaccine is an important milestone for Moderna's efforts toward respiratory disease preparedness," said Stéphane Bancel, Chief Executive Officer of Moderna. "Our ...